Recombinant Nocardia farcinica NADH-quinone oxidoreductase subunit K (nuoK)

Shipped with Ice Packs
In Stock

Description

Introduction to Recombinant Nocardia farcinica NADH-Quinone Oxidoreductase Subunit K (nuoK)

Recombinant Nocardia farcinica NADH-quinone oxidoreductase subunit K (nuoK) is a His-tagged, full-length protein (1–99 amino acids) expressed in Escherichia coli. It belongs to Complex I of the bacterial electron transport chain, which catalyzes the transfer of electrons from NADH to ubiquinone, generating proton gradients for ATP synthesis . The protein is identified by UniProt ID Q5YWD6 and encoded by the nuoK gene (NFA_26580), with synonyms including NDH-1 subunit K .

Protein Properties

ParameterValue/DescriptionSource
Amino Acid SequenceMNPANYLFLSALLFTIGAAGVLLRRNAIVVFMCIELMLNAVNLAFVTFARMHANLDGQVF AFFTMVVAAAEVVVGLAIIMTIFRARRSTSVDDANLLKF
Molecular Weight~11 kDa (estimated from 99 aa)
Purity>90% (SDS-PAGE)
Storage BufferTris/PBS-based buffer, 6% trehalose, pH 8.0
Expression SystemE. coli

Functional Role

nuoK is critical for the assembly and activity of Complex I, which is essential for bacterial respiration. In N. farcinica, this complex may contribute to its adaptability in diverse environments, including host tissues, due to paralogous gene expansions linked to metabolic versatility .

Diagnostic and Immunological Use

  • ELISA Applications: Recombinant nuoK is used in immunoassays to detect antibodies against N. farcinica, aiding in serological diagnostics .

  • Antigenicity: While not directly studied, related proteins like NFA49590 in N. farcinica exhibit immunoprotective potential, suggesting nuoK may serve as a vaccine candidate or diagnostic marker .

Table 1: Amino Acid Sequence and Functional Domains

RegionSequence (Partial)Functional Relevance
N-terminalMNPANYLFLSALLFTIGAAGVLLRRNAIVVFMCIELMLNAVNLAFVTFARMHANLDGQVFMembrane-anchoring motifs (hydrophobic residues)
CentralAFFTMVVAAAEVVVGLAIIMTIFRARRSTSVDDANLLKFSubunit interaction sites (charged residues)

Table 2: Supplier Comparison

SupplierProduct CodeKey FeaturesLimitations
Creative BioMartRFL34733NFFull-length, His-tagged, high purityLimited functional data
LabPriceCSB-YP733481NAAAPartial sequence, yeast expressionLower sequence coverage
CusabioCF373476RIZELISA-optimized, pre-coated platesHigher cost for diagnostic use

Product Specs

Form
Lyophilized powder
Note: While we prioritize shipping the format currently in stock, please specify your format preference during order placement for customized preparation.
Lead Time
Delivery times vary depending on the purchasing method and location. Please contact your local distributor for precise delivery estimates.
Note: All proteins are shipped with standard blue ice packs. Dry ice shipping requires prior arrangement and incurs additional charges.
Notes
Avoid repeated freeze-thaw cycles. Store working aliquots at 4°C for up to one week.
Reconstitution
Centrifuge the vial briefly before opening to consolidate the contents. Reconstitute the protein in sterile, deionized water to a concentration of 0.1-1.0 mg/mL. We recommend adding 5-50% glycerol (final concentration) and aliquoting for long-term storage at -20°C/-80°C. Our default glycerol concentration is 50%, offered as a guideline for your use.
Shelf Life
Shelf life depends on several factors: storage conditions, buffer composition, temperature, and protein stability. Generally, liquid formulations have a 6-month shelf life at -20°C/-80°C, while lyophilized forms have a 12-month shelf life at -20°C/-80°C.
Storage Condition
Upon receipt, store at -20°C/-80°C. Aliquoting is essential for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
The tag type is determined during the manufacturing process.
The tag type is determined during production. If you require a specific tag, please inform us; we will prioritize development of your specified tag.
Synonyms
nuoK; NFA_26580; NADH-quinone oxidoreductase subunit K; NADH dehydrogenase I subunit K; NDH-1 subunit K
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-99
Protein Length
full length protein
Species
Nocardia farcinica (strain IFM 10152)
Target Names
nuoK
Target Protein Sequence
MNPANYLFLSALLFTIGAAGVLLRRNAIVVFMCIELMLNAVNLAFVTFARMHANLDGQVF AFFTMVVAAAEVVVGLAIIMTIFRARRSTSVDDANLLKF
Uniprot No.

Target Background

Function
NDH-1 facilitates electron transfer from NADH, via FMN and iron-sulfur (Fe-S) centers, to quinones within the respiratory chain. In this organism, the primary electron acceptor is believed to be a menaquinone. The enzyme couples this redox reaction to proton translocation; for every two electrons transferred, four protons are translocated across the cytoplasmic membrane, conserving redox energy as a proton gradient.
Database Links
Protein Families
Complex I subunit 4L family
Subcellular Location
Cell membrane; Multi-pass membrane protein.

Q&A

What is Nocardia farcinica NADH-quinone oxidoreductase subunit K and what is its significance in research?

NADH-quinone oxidoreductase subunit K (nuoK) is a membrane protein component of the respiratory chain complex I in Nocardia farcinica. It plays a critical role in the electron transport chain and energy metabolism of this bacterium. The protein consists of 99 amino acids and is characterized by its hydrophobic transmembrane regions. In research contexts, this protein is significant because it represents an essential component of bacterial energy metabolism and could potentially serve as a target for antimicrobial development, especially given N. farcinica's clinical significance as an opportunistic pathogen . Understanding this protein's structure and function contributes to our knowledge of bacterial respiration and potential therapeutic interventions against Nocardia infections.

What are the general characteristics of recombinant nuoK protein from Nocardia farcinica?

The recombinant nuoK protein from Nocardia farcinica (strain IFM 10152) is typically produced with a molecular tag (though the tag type may vary depending on production processes). The full amino acid sequence is: MNPANYLFISALLFTIVGAAGVLLRRNAIVVFMCIEIMLNAVNLAFVTFARMHANLDGQVFAFFTMVVAAAEVVVGLAIIMTIFRARGRSTSVDDANLLKF. The protein consists of 99 amino acids and has a primary function as part of the NADH dehydrogenase complex (EC 1.6.99.5) . When produced recombinantly, it is generally stored in Tris-based buffer with 50% glycerol and should be maintained at -20°C or -80°C for extended storage. Researchers should note that repeated freeze-thaw cycles can compromise protein integrity, and working aliquots are best stored at 4°C for up to one week .

How is Nocardia farcinica identified in laboratory settings?

For more precise and rapid identification, PCR-based molecular methods have been developed. Specifically, a PCR assay using primers Nf1 and Nf2 (16-mer primers) can generate a characteristic 314-bp fragment that is specific to N. farcinica. This allows for identification within one day of obtaining DNA, compared to the weeks required for traditional methods. The specificity of this assay has been verified against other Nocardia species and related bacterial genera . Additionally, restriction enzyme digestion using CfoI and direct sequencing of the 314-bp fragment can further confirm the identification of N. farcinica strains.

What experimental conditions are optimal for handling recombinant nuoK protein?

Based on established protocols for similar recombinant proteins, the optimal conditions for handling recombinant nuoK include:

  • Storage: Maintain stock solutions at -20°C to -80°C in a Tris-based buffer with 50% glycerol.

  • Working conditions: Create small aliquots to avoid repeated freeze-thaw cycles. Working aliquots can be stored at 4°C for up to one week.

  • Buffer conditions: Tris-based buffers at physiological pH (7.2-7.4) are typically suitable.

  • Stability considerations: The protein contains multiple hydrophobic transmembrane domains, making it potentially challenging to maintain in solution. Detergents like n-dodecyl β-D-maltoside (DDM) at 0.1-0.5% may help stabilize the protein in solution during experimental manipulations .

  • Experimental use: When designing experiments, consider the membrane-embedded nature of this protein and its natural function in electron transport.

What are the methodological challenges in expressing and purifying recombinant nuoK from Nocardia farcinica?

Expression and purification of recombinant nuoK present several significant challenges due to its integral membrane nature:

  • Expression system selection: E. coli-based expression systems may struggle with proper folding of this membrane protein. Alternative expression hosts like Pichia pastoris or insect cell systems might yield better results for maintaining proper protein conformation.

  • Solubility issues: As an integral membrane protein with multiple transmembrane domains, nuoK has low solubility in aqueous solutions. Researchers must optimize detergent types and concentrations to extract and maintain the protein in solution without denaturing it. Commonly used detergents include DDM, LDAO, or OG at concentrations between 0.1-1% depending on the experimental phase.

  • Purification strategy: A multi-step purification approach is typically required:

    • Initial extraction with appropriate detergents

    • Affinity chromatography utilizing the affinity tag (His-tag is common)

    • Size exclusion chromatography to remove aggregates

    • Ion exchange chromatography for final polishing

  • Protein stability: nuoK is prone to aggregation and precipitation during purification. Stabilizing agents such as glycerol (10-20%) and specific lipids might be necessary to maintain protein stability throughout purification.

  • Verification of proper folding: Circular dichroism spectroscopy can be employed to confirm that the recombinant protein maintains its predominantly alpha-helical secondary structure after purification .

How can experimental design approaches be optimized for studying nuoK function in vitro?

Optimizing experimental design for studying nuoK function requires careful consideration of several factors:

  • Reconstitution systems: Since nuoK functions as part of a multi-subunit complex, reconstitution in proteoliposomes or nanodiscs can provide a more native-like environment for functional studies. This approach allows for:

    • Control over lipid composition

    • Orientation of the protein in the membrane

    • Integration with other complex I components

  • Electron transport assays: Measuring electron transfer activity requires specialized approaches:

    • NADH:ubiquinone oxidoreductase activity assays using artificial electron acceptors

    • Oxygen consumption measurements using Clark-type electrodes

    • Membrane potential measurements using fluorescent probes

  • Inhibitor studies: Comparing the effects of known Complex I inhibitors on recombinant nuoK versus the native complex can provide insights into functional integrity.

  • Control experiments: Design must include:

    • Negative controls with denatured protein

    • Positive controls with well-characterized related proteins

    • Tests for non-specific effects of buffer components and detergents

  • Data analysis: Complex kinetic data from electron transport studies should be analyzed using appropriate models:

    • Michaelis-Menten kinetics for substrate affinity

    • Hill equation analysis for cooperative effects

    • Global fitting approaches for multi-parameter data sets

This experimental framework follows Campbell and Stanley's principles for robust experimental design, incorporating appropriate controls and quantitative analysis methods .

What are the current limitations in structural characterization of nuoK and how might they be addressed?

Structural characterization of nuoK faces several significant challenges:

  • Current limitations:

    • High hydrophobicity makes traditional structural biology approaches difficult

    • Small size (99 amino acids) limits signal in certain spectroscopic methods

    • Membrane integration complicates isolation in native conformation

    • Function as part of a large complex means isolated structures may not reflect native state

  • Potential methodological solutions:

    • X-ray crystallography: Requires specialized crystallization approaches for membrane proteins, such as lipidic cubic phase crystallization or the use of crystallization chaperones.

    • Cryo-electron microscopy: Recent advances in single-particle cryo-EM have made it possible to resolve structures of membrane proteins without crystallization. This might be applied to the entire Complex I with specific focus on the nuoK subunit.

    • NMR spectroscopy: Solution NMR with isotopically labeled protein in detergent micelles or solid-state NMR in lipid bilayers could provide structural information, particularly on dynamics.

    • Computational approaches: Homology modeling based on related bacterial Complex I structures combined with molecular dynamics simulations can provide structural insights when experimental data is limited.

  • Integrated approaches:

    • Combining low-resolution structural data with computational modeling

    • Using cross-linking mass spectrometry to establish proximity constraints

    • Employing hydrogen-deuterium exchange mass spectrometry to probe surface accessibility

  • Novel technologies:

    • Microfluidic approaches for rapid screening of stabilizing conditions

    • Nanobody-assisted structure determination to stabilize specific conformations

    • In-cell structural biology methods to observe the protein in its native environment

How does antibiotic resistance relate to research on Nocardia farcinica nuoK?

The relationship between antibiotic resistance and nuoK research presents several interesting research angles:

  • Metabolic adaptations and resistance:

    • While nuoK itself is not directly implicated in antibiotic resistance mechanisms, alterations in respiratory chain function can affect susceptibility to certain antibiotics.

    • Research suggests that bacteria may modulate their respiratory chain components in response to antibiotic stress, potentially affecting nuoK expression or function.

  • Genomic context insights:

    • Whole genome sequencing of resistant N. farcinica strains has revealed that some resistance mechanisms, particularly to trimethoprim-sulfamethoxazole (SXT), are transposon-mediated.

    • The sul1 gene, carried on IS6-composite transposons, confers sulfamethoxazole resistance with MICs up to 32/608 μg/mL .

    • Understanding the genomic context around the nuoK gene could reveal whether it is subject to similar mobile genetic element influences.

  • Experimental approaches to investigate potential relationships:

    • Comparative transcriptomics of susceptible versus resistant strains to assess nuoK expression differences

    • Mutagenesis studies to determine if altered nuoK function affects antibiotic susceptibility

    • Metabolic flux analysis to identify shifts in respiratory chain activity in resistant strains

  • Clinical relevance:

    • N. farcinica is increasingly recognized as an opportunistic pathogen with intrinsic resistance to multiple antibiotics.

    • 88% of disseminated N. farcinica cases are associated with underlying malignancy or autoimmune disease .

    • Connecting respiratory chain function to antibiotic efficacy could provide new therapeutic avenues.

AntibioticResistance MechanismGenomic ContextRelation to Respiratory Function
Trimethoprim-Sulfamethoxazolesul1 gene on IS6-composite transposonPlasmid-bornePotential metabolic compensations
Beta-lactamsMultiple mechanismsChromosomal and plasmidOften involves energy-dependent efflux
AminoglycosidesVariesTypically chromosomalUptake is membrane-potential dependent

What PCR-based approaches can be used for detecting and studying the nuoK gene in clinical Nocardia farcinica isolates?

PCR-based approaches for detecting and studying the nuoK gene can be implemented through several methodologies:

  • Specific gene amplification:

    • Design primers targeting conserved regions of the nuoK gene based on reference sequences

    • Recommended conditions: initial denaturation at 95°C for 5 minutes, followed by 30-35 cycles of denaturation (95°C, 30 seconds), annealing (55-60°C, 30 seconds), and extension (72°C, 30-45 seconds)

    • Verification by agarose gel electrophoresis and sequencing of the amplicon

  • Species identification using established primers:

    • The Nf1 and Nf2 primer pair generates a characteristic 314-bp fragment specific to N. farcinica, allowing for species confirmation before nuoK-specific studies

    • This can be followed by restriction enzyme digestion using CfoI to further confirm specificity

  • Expression analysis:

    • RT-PCR or qRT-PCR to quantify nuoK expression levels under different growth conditions

    • Normalization against stable reference genes is essential for accurate quantification

    • Protocol should include DNase treatment of RNA samples to prevent genomic DNA contamination

  • Sequence variation analysis:

    • Following amplification, direct sequencing to identify potential mutations or polymorphisms

    • Comparative analysis against reference sequences to identify functional implications of any variations

    • Construction of phylogenetic trees to understand evolutionary relationships among nuoK variants

  • RAPD analysis:

    • Random Amplified Polymorphic DNA analysis using primer DKU49 can generate a characteristic 409-bp band in N. farcinica isolates

    • This approach can complement specific gene amplification to confirm species identity

How can functional assays be designed to assess nuoK activity in relation to NADH-quinone oxidoreductase complex?

Designing functional assays for nuoK activity requires approaches that account for its role within the larger NADH-quinone oxidoreductase complex:

  • Spectrophotometric enzyme activity assays:

    • NADH oxidation can be monitored by decrease in absorbance at 340 nm

    • Reaction mixture typically contains 50 mM phosphate buffer (pH 7.4), 0.1 mM NADH, 0.1 mM ubiquinone analog (Q1 or decylubiquinone), and protein sample

    • Specific activity calculated as nmol NADH oxidized/min/mg protein

    • Control reactions with specific inhibitors (rotenone, piericidin A) to confirm specificity

  • Reconstitution experiments:

    • Expression of recombinant nuoK in systems lacking endogenous Complex I

    • Complementation analysis to determine if nuoK can restore function in deficient systems

    • Co-expression with other Complex I subunits to assess assembly dependencies

  • Membrane potential measurements:

    • Use of potential-sensitive fluorescent dyes (TMRM, DiSC3(5), JC-1)

    • Protocol includes preparing bacterial spheroplasts or proteoliposomes containing nuoK

    • Monitoring fluorescence changes upon substrate addition with/without inhibitors

    • Controls should include uncouplers (CCCP) to abolish membrane potential

  • Oxygen consumption assays:

    • Clark-type oxygen electrode measurements in isolated membranes or reconstituted systems

    • Reaction chamber typically contains 10-50 μg protein in buffer with 0.2-0.5 mM NADH

    • Rate calculated as nmol O2 consumed/min/mg protein

    • Inhibitor sensitivity profile helps confirm specific Complex I activity

  • Site-directed mutagenesis approaches:

    • Systematic mutation of conserved residues in nuoK to identify functionally important amino acids

    • Expression of mutant variants followed by activity assays

    • Comparison to wild-type protein to quantify effects on electron transport and proton pumping

Assay TypeMeasurable ParameterEquipmentKey Controls
NADH oxidationAbsorbance decrease at 340 nmSpectrophotometerRotenone inhibition
Membrane potentialFluorescence intensityFluorimeterCCCP uncoupler
Oxygen consumptionDissolved O2 concentrationOxygen electrodeAntimycin A inhibition
Superoxide formationChemiluminescenceLuminometerSOD addition

What are the best approaches for studying protein-protein interactions involving nuoK in the respiratory chain complex?

Studying protein-protein interactions involving nuoK requires specialized approaches due to its membrane-embedded nature:

  • Cross-linking mass spectrometry (XL-MS):

    • Chemical cross-linkers (DSS, BS3, or photoreactive crosslinkers) are added to purified complex or membrane preparations

    • Cross-linked products are digested with proteases and analyzed by LC-MS/MS

    • Identified cross-linked peptides provide distance constraints between interacting regions

    • Data analysis requires specialized software (pLink, xQuest, or Kojak) to identify cross-linked peptides

  • Co-immunoprecipitation strategies:

    • Generation of antibodies against nuoK or use of epitope-tagged versions

    • Solubilization of membranes with mild detergents (DDM, digitonin)

    • Immunoprecipitation followed by Western blotting or MS identification of co-precipitating proteins

    • Controls should include non-specific antibodies and denaturing conditions

  • Bacterial two-hybrid systems:

    • Adaptation of bacterial two-hybrid systems (BACTH) for membrane proteins

    • Fusion of nuoK and potential interaction partners to split adenylate cyclase domains

    • Interaction leads to functional complementation detected by reporter gene expression

    • Control constructs with known interacting and non-interacting pairs are essential

  • FRET-based approaches:

    • Fusion of fluorescent proteins to nuoK and potential interaction partners

    • Measurement of Förster resonance energy transfer as indicator of proximity

    • Live-cell measurements possible with appropriate expression systems

    • Requires careful controls for expression levels and fluorophore functionality

  • Surface plasmon resonance (SPR):

    • Immobilization of purified nuoK on sensor chip in detergent or lipid environment

    • Flowing potential interaction partners over the surface

    • Real-time monitoring of binding and dissociation kinetics

    • Multiple surface chemistries may need to be tested for optimal results

These methodological approaches must be carefully optimized for membrane proteins, with particular attention to maintaining the native structure of nuoK throughout the experimental procedures .

How can researchers overcome challenges in structural studies of membrane proteins like nuoK?

Overcoming structural study challenges for membrane proteins like nuoK requires multifaceted approaches:

  • Protein stability optimization:

    • Systematic screening of detergents (DDM, LMNG, GDN, DMNG)

    • Addition of lipids (POPC, POPE, cardiolipin) to mimic native environment

    • Incorporation of stabilizing additives (glycerol, specific ions, cholesterol hemisuccinate)

    • Testing thermostabilizing mutations identified through alanine scanning or directed evolution

    • Implementation of the lipidic cubic phase method for crystallization

  • Advanced expression strategies:

    • Use of specialized expression hosts (C41/C43 E. coli strains, Pichia pastoris)

    • Fusion to stability-enhancing partners (SUMO, MBP, thermostabilized GFP)

    • Codon optimization for expression host

    • Control of expression rate through temperature reduction and inducer concentration

    • Co-expression with chaperones to aid proper folding

  • Novel structural biology approaches:

    • Single-particle cryo-EM of detergent-solubilized or nanodisc-incorporated protein

    • Electron crystallography of 2D crystals

    • Micro-electron diffraction (microED) for small 3D crystals

    • Solid-state NMR of reconstituted protein in lipid bilayers

    • X-ray free electron laser (XFEL) studies with microcrystals

  • Integrated structural approaches:

    • Combination of low-resolution data (SAXS, negative stain EM) with computational modeling

    • Use of evolutionary coupling analysis to predict contacts between transmembrane helices

    • Distance constraints from EPR spectroscopy with site-directed spin labeling

    • Hydrogen-deuterium exchange mass spectrometry to map accessible regions

    • Molecular dynamics simulations to refine models against experimental constraints

  • Fragment-based approaches:

    • Division of protein into structurally stable domains

    • Parallel structural studies of individual domains

    • Computational integration of domain structures into a composite model

    • Validation of composite models using full-length protein data

Each approach has strengths and limitations, and researchers typically need to employ multiple complementary methods to obtain a complete structural understanding of complex membrane proteins like nuoK .

How should researchers interpret contradictory experimental results when studying nuoK function?

When confronted with contradictory experimental results in nuoK functional studies, researchers should implement a systematic interpretation framework:

  • Data validation and quality assessment:

    • Evaluate experimental reproducibility through statistical analysis of replicate experiments

    • Assess signal-to-noise ratios and determine if contradictions might result from data near detection limits

    • Verify that control experiments performed as expected in each contradictory dataset

    • Examine raw data for outliers or instrumental artifacts that might skew interpretations

  • Methodological reconciliation approach:

    • Compare experimental conditions in detail (buffer composition, pH, temperature, protein concentration)

    • Consider time-dependent effects that might explain differences between immediate and delayed measurements

    • Evaluate differences in protein preparation methods that could affect functional state

    • Assess whether different detergents or lipid environments could account for functional differences

  • Biological explanations for contradictions:

    • Consider allosteric effects or post-translational modifications that might create multiple functional states

    • Evaluate whether nuoK might have differential activity depending on association with other complex components

    • Assess whether the protein exhibits different properties at different concentrations (oligomerization effects)

    • Consider species-specific or strain-specific variations that might explain functional differences

  • Experimental design for resolution:

    • Design new experiments specifically targeting the contradiction

    • Implement orthogonal methods to test the same property by different approaches

    • Develop control experiments that can distinguish between alternative hypotheses

    • Use reconstitution experiments to systematically test component effects

  • Integration with existing knowledge:

    • Compare contradictory results with published data on related systems

    • Use computational models to evaluate whether contradictions fit within theoretical frameworks

    • Consult experts in specialized techniques for insight into methodological limitations

    • Consider whether contradictions might reveal novel aspects of nuoK biology

These approaches align with Campbell and Stanley's experimental design principles, employing multiple measures and controls to resolve apparent contradictions .

What bioinformatic approaches are most valuable for analyzing nuoK sequence and structure in relation to other species?

Bioinformatic analysis of nuoK requires specialized approaches tailored to membrane proteins:

  • Sequence-based analyses:

    • Multiple sequence alignment using membrane protein-optimized algorithms (PRALINE, TM-Coffee)

    • Conservation analysis to identify functionally important residues across species

    • Hydropathy plot analysis (TMHMM, TOPCONS) to predict transmembrane regions

    • Coevolution analysis (EVfold, GREMLIN) to predict residue contacts within the protein structure

    • Taxonomic distribution analysis to understand evolutionary patterns

  • Structure prediction approaches:

    • Homology modeling based on related bacterial Complex I structures

    • De novo structure prediction using specialized membrane protein protocols in Rosetta or AlphaFold

    • Molecular dynamics simulations in explicit membrane environments to refine models

    • Coarse-grained simulations to study large-scale conformational changes

    • Model validation using ProSA, QMEANBrane, and other membrane protein-specific metrics

  • Comparative analysis workflows:

    • Phylogenetic tree construction to understand evolutionary relationships

    • Selection pressure analysis (dN/dS ratios) to identify potentially adaptive sites

    • Structure-based sequence alignments to compare functionally equivalent positions

    • Analysis of co-evolving residue networks across the protein family

  • Functional site prediction:

    • Identification of conserved motifs using MEME, GLAM2

    • Binding site prediction using CASTp, COACH, or COFACTOR

    • Electrostatic surface analysis to identify potential interaction interfaces

    • Identification of potentially post-translationally modified residues

  • Data integration platforms:

    • Construction of custom nuoK-focused databases integrating sequence, structural, and functional data

    • Network analysis of protein-protein interactions across species

    • Pathway enrichment analysis to understand broader metabolic context

    • Machine learning approaches to predict functional properties from sequence features

Bioinformatic ApproachSoftware ToolsPrimary ApplicationsLimitations
Transmembrane predictionTMHMM, TOPCONSTopology mappingMay miss weakly hydrophobic helices
Homology modelingSWISS-MODEL, Phyre2Structure predictionDepends on available templates
Coevolution analysisEVfold, GREMLINContact predictionRequires large, diverse alignments
Molecular dynamicsGROMACS, NAMDDynamic behaviorComputationally intensive
Conservation mappingConSurf, ScoreconsFunctional site predictionRequires careful alignment quality control

How can researchers design experimental controls specific to nuoK functional studies?

Designing appropriate experimental controls for nuoK functional studies requires careful consideration of both positive and negative controls:

  • Protein-level controls:

    • Denatured protein control: Heat-denatured nuoK preparations to establish baseline non-specific activity

    • Site-directed mutagenesis controls: Mutations in key conserved residues to create predictably non-functional variants

    • Tagged protein controls: Comparison of tagged versus untagged protein to assess tag interference

    • Concentration-matched controls: Using equivalent amounts of non-related membrane proteins to control for non-specific effects

  • Assay-specific controls:

    • Enzymatic activity controls:

      • Specific inhibitor controls (rotenone, piericidin A) to confirm Complex I-specific activity

      • Substrate specificity controls using structural analogs of natural substrates

      • Uncoupler controls (CCCP, valinomycin) to distinguish electron transport from proton pumping

    • Protein interaction controls:

      • Negative interaction controls using membrane proteins known not to interact with nuoK

      • Positive interaction controls using known Complex I subunit interactions

      • Competition controls with unlabeled proteins to verify binding specificity

  • System-specific controls:

    • Reconstitution controls:

      • Empty liposomes/nanodiscs to control for background effects

      • Reconstitution with individual components versus complete systems

      • Variation in lipid composition to assess environment-dependent effects

    • Genetic system controls:

      • Complementation with wild-type nuoK in knockout systems

      • Empty vector controls for expression systems

      • Inducible expression systems with and without inducer

  • Technical controls:

    • Buffer composition controls to assess ionic strength and pH effects

    • Detergent-only controls in solubilized protein experiments

    • Time-dependent controls to assess stability over experimental timeframes

    • Temperature controls to identify optimal conditions and potential artifacts

  • Data analysis controls:

    • Randomization of sample processing order to minimize systematic errors

    • Blinded analysis where possible to prevent observer bias

    • Technical replicates to assess measurement variability

    • Biological replicates to assess sample-to-sample variation

This systematic approach to control design follows established principles of experimental research design, ensuring that observed effects can be confidently attributed to nuoK function .

What emerging technologies hold promise for advancing nuoK research?

Several emerging technologies show significant potential for advancing nuoK research:

  • Advanced structural biology approaches:

    • Micro-electron diffraction (MicroED) for structural analysis of small crystals

    • Time-resolved cryo-EM to capture conformational states during the catalytic cycle

    • Cryo-electron tomography with subtomogram averaging for in situ structural studies

    • Integrative structural biology combining multiple data types for complete models

  • Novel protein engineering methods:

    • In vivo directed evolution using continuous selection systems

    • Non-canonical amino acid incorporation for precise functional probing

    • Protein semi-synthesis for incorporation of post-translational modifications

    • Nanobody development for stabilization of specific conformational states

  • Single-molecule approaches:

    • Single-molecule FRET to study conformational dynamics

    • Patch-clamp fluorometry to correlate structure with function

    • Magnetic tweezers or optical traps to study energetics of conformational changes

    • Nanopore-based single-molecule electrophysiology

  • Advanced computational methods:

    • Machine learning for predicting protein-protein interactions and functional sites

    • Quantum mechanics/molecular mechanics simulations for reaction mechanism studies

    • Markov state modeling of conformational dynamics

    • Enhanced sampling methods for energy landscape exploration

  • Systems biology integration:

    • Multi-omics approaches connecting nuoK to broader cellular processes

    • Metabolic flux analysis to understand energetic contributions

    • Whole-cell modeling incorporating detailed respiratory chain components

    • Network analysis of protein interactions in different physiological states

These emerging technologies provide opportunities to address fundamental questions about nuoK structure, function, and integration into cellular metabolism that have been challenging with traditional approaches .

How might nuoK research contribute to understanding antibiotic resistance mechanisms in Nocardia farcinica?

The intersection of nuoK research and antibiotic resistance mechanisms presents several promising research avenues:

  • Metabolic adaptation mechanisms:

    • Investigation of respiratory chain remodeling in response to antibiotic pressure

    • Analysis of nuoK expression changes in resistant versus susceptible strains

    • Metabolic flux analysis to identify shifts in energy generation pathways

    • Determination whether alterations in electron transport affect antibiotic uptake or efflux

  • Genomic context analysis:

    • Comparative genomics of nuoK gene neighborhood across resistant isolates

    • Investigation of potential co-selection of respiratory chain components with resistance genes

    • Analysis of regulatory elements affecting both nuoK expression and resistance mechanisms

    • Identification of potential horizontal gene transfer events affecting respiratory chain genes

  • Functional implications:

    • Assessment of membrane potential differences between susceptible and resistant strains

    • Investigation of how electron transport chain function affects persistence under antibiotic stress

    • Determination if proton motive force alterations contribute to antibiotic tolerance

    • Exploration of Complex I inhibitors as potential antibiotic adjuvants

  • Clinical correlations:

    • Analysis of clinical isolates for correlations between nuoK sequence variants and resistance profiles

    • Investigation of whether specific mutations in nuoK correlate with treatment failures

    • Study of how host environments might select for both respiratory adaptations and resistance

    • Examination of metabolic signatures as predictive biomarkers for resistance development

  • Therapeutic targeting strategies:

    • Evaluation of respiratory chain components as novel drug targets

    • Investigation of synergistic effects between respiratory inhibitors and conventional antibiotics

    • Development of approaches to prevent metabolic adaptation to antibiotic stress

    • Design of dual-action compounds affecting both resistance mechanisms and energy metabolism

These research directions could substantially advance our understanding of how fundamental bacterial energetics interact with antibiotic resistance mechanisms, potentially leading to novel therapeutic approaches for recalcitrant Nocardia infections .

What interdisciplinary approaches could enhance our understanding of nuoK structure-function relationships?

Advancing our understanding of nuoK structure-function relationships would benefit significantly from interdisciplinary approaches:

  • Integrating structural biology with electrophysiology:

    • Correlation of structural states with proton translocation activity

    • Patch-clamp studies of reconstituted nuoK in model membrane systems

    • Voltage-sensor measurements combined with site-directed spin labeling

    • Time-resolved structural studies synchronized with functional measurements

  • Combining biophysics with computational biology:

    • Molecular dynamics simulations validated by spectroscopic measurements

    • Quantum mechanical calculations of electron transfer rates constrained by experimental data

    • Free energy calculations to predict binding affinities and compare with experimental values

    • Machine learning approaches trained on experimental data to predict functional properties

  • Metabolic engineering and synthetic biology applications:

    • Creation of minimal respiratory chain systems incorporating engineered nuoK variants

    • Design of synthetic electron transport chains with modified quinone binding sites

    • Development of biosensors based on nuoK conformational changes

    • Engineering of hybrid systems combining components from different species

  • Clinical microbiology and molecular evolution integration:

    • Analysis of natural nuoK variants from clinical isolates for functional differences

    • Ancestral sequence reconstruction to understand evolutionary trajectories

    • Experimental evolution under different selective pressures to identify adaptive mutations

    • Correlation of sequence variations with clinical outcomes in Nocardia infections

  • Systems biology and multi-omics approaches:

    • Integration of transcriptomics, proteomics, and metabolomics data

    • Flux balance analysis incorporating nuoK-dependent reactions

    • Network modeling of respiratory chain interactions with other cellular processes

    • Global analysis of genetic interactions affecting nuoK function

These interdisciplinary approaches would provide comprehensive insights into nuoK biology beyond what could be achieved through any single methodology, potentially revealing novel aspects of respiratory chain function and regulation that could inform therapeutic strategies .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.